Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$89,088
in 5 filings, $89K under 10b5-1 plans

Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. O'Neill Gilmore Neil −$67K CEO sold 9% of stake
  2. Burkly Linda −$21K EVP, CHIEF SCIENTIFIC OFFICER sold 11% of stake
  3. Parison Amy −$1K SVP, Chief Financial Officer sold 3% of stake

Reading 4 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion +404,253 914,138
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion +76,922 991,060
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion · Series A-1 Preferred Stock −5,302,834 0
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion · Series A-2 Preferred Stock −4,204,240 0
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion · Series B Preferred Stock −800,001 0
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion · Series A-1 Preferred Stock −1,325,708 0
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion · Series A-2 Preferred Stock −1,051,060 0
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion · Series B Preferred Stock −199,999 0
2016-02-08 Bitterman Kevin Director Conversion +2,549,435 2,549,435
2016-02-08 Bitterman Kevin Director Conversion +2,021,269 4,570,704
2016-02-08 Bitterman Kevin Director Conversion +85,469 4,656,173
2016-02-08 Bitterman Kevin Director Conversion · Series A-1 Preferred Stock −6,628,542 0
2016-02-08 Bitterman Kevin Director Conversion · Series A-2 Preferred Stock −5,255,300 0
2016-02-08 Bitterman Kevin Director Conversion · Series B Preferred Stock −222,222 0
2016-02-08 Borisy Alexis Director Conversion +0 0
2016-02-08 Borisy Alexis Director Conversion · Series A-1 Preferred Stock −0 0
2016-02-08 Borisy Alexis Director Conversion · Series A-2 Preferred Stock −0 0
2016-02-08 Borisy Alexis Director Conversion · Series B Preferred Stock −0 0
2016-02-08 Nikolic Boris Director Conversion +2,649,572 2,649,572
2016-02-08 Nikolic Boris Director Conversion · Series B Preferred Stock +6,888,888 0

Page 27 of 30 · 588 trades